GlassScriptPhysician profile
Michael Woo Lee
NPI 1477845956
$1,380.65
in general payments reported to CMS, 2019-2025
16 companies · $252 in 2025
The $252 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.06 · 2020: $105 · 2021: $179 · 2022: $322 · 2023: $151 · 2024: $331 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $237.24 | 2021-2024 | Kristalose |
| Glaxosmithkline, LLC. | $173.57 | 2022-2024 | Bexsero |
| Cranial Technologies, INC | $154.01 | 2020-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $125.00 | 2024 | |
| Sobi, INC | $122.57 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $108.68 | 2021-2025 | Gardasil 9, Enflonsia, Vaxneuvance |
| Alk-Abello, INC | $96.90 | 2024-2025 | Grastek, Ragwitek, Odactra |
| Seqirus USA INC | $85.26 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Sanofi Pasteur INC. | $70.43 | 2023-2025 | |
| Pfizer INC. | $59.44 | 2019-2022 | |
| Phadia US INC. | $29.39 | 2023-2025 | Immunocap |
| Aytu Biopharma, INC. | $27.78 | 2024-2025 | Karbinal |
| Alexion Pharmaceuticals, INC. | $27.55 | 2025 | Koselugo |
| Astrazeneca Pharmaceuticals LP | $26.45 | 2024 | Flumist Quadrivalent |
| Qiagen, LLC | $22.32 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.06 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.